U.S. Biotech Stock News

In recent months, GameStop has accelerated closures of its brick-and-mortar stores while allocating part of its sizable cash reserves into Bitcoin, reflecting the ongoing shift of gamers toward digital downloads. This combination of a shrinking physical footprint and increased exposure to cryptocurrency highlights how the company is reshaping its business mix and risk profile. With these changes unfolding, we will examine how GameStop’s store closures and Bitcoin holdings influence its...

Synchrony Financial (SYF) reported fourth quarter results with net interest income of US$4,761 million and net income of US$751 million, and confirmed it has completed its US$2.3b share repurchase program. See our latest analysis for Synchrony Financial. The completed US$2.3b buyback, ongoing common and preferred dividends, and the latest earnings update come against a mixed share price backdrop. There has been a 3.48% 7 day share price return, a 13.50% 1 month share price decline, and a...

In early February 2026, ESCO Technologies Inc. reported strong first-quarter 2026 results, with higher sales, earnings and orders, raised its full-year 2026 revenue and earnings guidance, and declared a US$0.08 per-share quarterly dividend payable on April 17, 2026 to shareholders of record on April 2, 2026. The company highlighted very large year-over-year order growth and a record US$1.40 billion backlog, underpinned by robust aerospace, defense and utility demand and an active acquisition...

The Timken Company reported fourth-quarter 2025 sales of US$1,111 million, up from US$1,073.6 million a year earlier, while net income eased to US$62.3 million and diluted EPS from continuing operations was US$0.89. Alongside modest full-year sales growth and lower 2025 earnings, Timken outlined 2026 guidance for higher revenue and EPS and highlighted an expanded 80/20 portfolio effort to exit underperforming businesses. Next, we’ll examine how Timken’s 80/20 portfolio expansion and 2026...

On January 20, 2026, iQIYI Inc. announced that Chief Financial Officer Jun Wang resigned for personal reasons and will serve as an advisor until May 31, while Senior Vice President of Finance Ying Zeng steps in as Interim CFO during the search for a permanent successor. This leadership transition places an experienced internal finance executive with IPO and financing background at the center of iQIYI’s financial decision-making during a key period. We’ll now examine how the CFO resignation...

Why Belden (BDC) Is On Investors’ Radar Today Belden (BDC) is drawing fresh attention after recent share price strength, with the stock up over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for Belden. The recent 6.1% 1 day share price return at a last close of $139.75, alongside a 22.5% 30 day share price return, sits against a 1 year total shareholder return of 21.6%, suggesting momentum has...

Why Radian Group Is On Investors’ Radar Today Radian Group (RDN) is back in focus after recent trading left the stock at US$33.56, with returns mixed across different time frames, including a small gain over the past year but declines month to date and year to date. See our latest analysis for Radian Group. Recent trading has been choppy, with a 7 day share price return of 2.01%, a 30 day share price return of 5.86%, and a year to date share price return of 6.57%. Longer term total...

Earnings shock and what it means for Liberty Broadband stock Liberty Broadband (LBRD.K) just posted full year 2025 results showing a net loss of US$2.676b, compared with net income of US$869m in 2024, putting its shift in profitability squarely in focus for investors. See our latest analysis for Liberty Broadband. The earnings announcement has landed after a period where the 1 day share price return of 3.34% and 7 day share price return of 11.74% lifted the stock to US$53.76. However, the 1...

What Qiagen (QGEN) offers and how the business makes money Qiagen (QGEN) focuses on what it calls sample to insight solutions, essentially turning raw biological material into molecular data that labs and clinicians can use in testing and research. The company generates revenue from a wide mix of consumables, instruments, and software used in molecular diagnostics, academic research, pharmaceutical development, and applied testing such as forensics and food safety. On the consumables side,...

Take-Two Interactive Software (TTWO) shares were in focus after the company reported third quarter and nine month results showing higher sales and revenue, narrower net losses, and an increased earnings outlook for fiscal 2026. See our latest analysis for Take-Two Interactive Software. The third quarter update and higher earnings outlook arrive after a tough stretch for the share price, with a 30 day share price return of 22% and a year to date share price return of 22.3%. The 3 year total...

SS&C Technologies Holdings (SSNC) is back in focus after reporting fourth quarter 2025 results that topped analyst expectations, paired with upbeat guidance and fresh client wins that point to ongoing business momentum. See our latest analysis for SS&C Technologies Holdings. The earnings beat and fresh client wins, including new agreements with Allspring, Saltus and Rareview Capital, come after a softer patch for the share price. The 30-day share price return shows an 11.09% decline and the...

In late January 2026, ResMed reported higher quarterly sales of US$1,422.81 million and net income of US$392.59 million, alongside declaring a US$0.60 per-share quarterly dividend payable on March 19, 2026, and confirming completion of a multi-year US$1.19 billion share buyback program. Beyond the headline results, management highlighted strong global demand for masks and devices, expanding digital health software, and supply-chain efficiencies that supported margin expansion during the...

LKQ (LKQ) has drawn fresh attention as investors reassess its recent share performance and fundamentals, with the stock closing at $34.58 and the company reporting annual revenue of US$14.1b and net income of US$696 million. See our latest analysis for LKQ. Recent trading has been constructive, with a 7 day share price return of 5.27% and a 90 day share price return of 11.69%. However, the 1 year total shareholder return shows a 3.96% decline, which contrasts with a modest 4.33% gain over 5...

In early February 2026, ConocoPhillips reported fourth-quarter 2025 results showing revenue of US$14,185 million and net income of US$1,442 million, both lower than a year earlier as weaker commodity prices pressured profitability despite higher reported production. Alongside these results, the company reaffirmed its plan to return 45% of cash from operations to shareholders in 2026, including an ordinary dividend of US$0.84 per share and ongoing share buybacks funded by a multi-year cost...

Steel Dynamics (STLD) has drawn attention after reporting full year 2025 results with sales of US$18,176.58 million, net income of US$1,185.6 million, and earnings per share below the prior year. See our latest analysis for Steel Dynamics. That mix of higher sales, softer earnings and an active buyback program appears to be feeding into sentiment, with a 32.78% 90 day share price return and a very large 5 year total shareholder return that suggests momentum has been strong over both shorter...

In recent months, Globus Medical has drawn attention for pairing strong fundamentals and a debt-free balance sheet with rapid expansion in musculoskeletal-focused technologies, including its ExcelsiusGPS robotic-assisted surgery platform and new Excelsius XR headset. At the same time, the company’s extensive innovation pipeline and leadership in healthcare digitization are being weighed against pressures such as longer robotics sales cycles, integration work following past acquisitions, and...

Qualcomm is facing a global shortage of memory chips that is limiting smartphone production and weighing on its latest outlook. Surging demand from AI data centers is tightening supply, leading handset makers, particularly in China, to pull back on orders and adjust inventory plans. In response, Qualcomm is putting more focus on areas such as automotive, IoT, robotics, data center solutions, and AI enabled devices to broaden its revenue base. NasdaqGS:QCOM currently trades at $137.34, with...

Ryan Specialty Holdings recently formed Ryan Specialty Canada Limited as a Toronto-headquartered operating and holding entity, appointing Stephen Stewart, already President & CEO of Stewart Specialty Risk Underwriting, as its Chief Executive Officer to oversee the amalgamated Canadian underwriting management businesses. This consolidation into a single Canadian platform, uniting multiple managing general underwriters under one leadership structure, could reshape how Ryan Specialty...

Recently, Hut 8 Corp. outlined its transition beyond traditional crypto mining by proposing a 500-megawatt data center near Latham and signing a 15-year, US$7.00 billion data center lease with Google-backed Fluidstack for its River Bend campus in Louisiana, while also agreeing to sell four Ontario natural gas-fired power plants to TransAlta. These moves mark a clear push into AI-oriented digital infrastructure, but they also raise fresh questions around energy use, local community impact and...

In early February 2026, Humana launched Agent Assist, an AI-powered tool built with Google Cloud to help more than 20,000 member advocates deliver faster, more accurate responses to health benefit questions across up to 80 million calls a year. This initiative highlights how Humana is trying to blend advanced AI with a human-in-the-loop approach to improve member experience, operational consistency, and compliance in its call centers. Next, we’ll examine how Humana’s Agent Assist rollout,...

In January 2026, Agilysys, Inc. reported third-quarter fiscal 2026 results showing revenue of US$80.39 million and net income of US$9.9 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier. The company also raised its fiscal 2026 earnings guidance to US$318 million in total revenue, signaling management’s confidence in its operational performance so far this year. We’ll now examine how Agilysys’s raised fiscal 2026 revenue guidance...

Oscar Health (OSCR) is back in focus after reaching profitability for the first time and heading into its fourth quarter and full year 2025 earnings on February 10, a key checkpoint for investors. See our latest analysis for Oscar Health. The profitability milestone has come during a rough patch for the stock, with a 30 day share price return of 30.96% decline and a year to date share price return of 18.24% decline, even though the 3 year total shareholder return is very large. That mix of...

Why Advanced Drainage Systems Stock Is On Investors’ Radar With no single headline event driving attention right now, Advanced Drainage Systems (WMS) has still drawn interest as investors look at how its recent share performance lines up with fundamentals. See our latest analysis for Advanced Drainage Systems. The recent move to a US$175.38 share price sits on top of a 15.35% 7 day share price return and a 17.21% year to date share price return, while the 1 year total shareholder return of...

If you are wondering whether Recursion Pharmaceuticals' current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers suggest about value. The stock last closed at US$3.98, after share price returns of a 5.0% decline over 7 days, 14.6% decline over 30 days, 5.2% decline year to date, and 46.9% decline over the past year, with a 51.4% decline over three years. Recently, headlines around Recursion Pharmaceuticals have focused on its...